Thymosin Alpha-1 (10 mg Vial) Dosage Protocol
Thymosin Alpha-1 is a 28-amino-acid peptide originally isolated from thymus extract. It modulates T-cell function and immune response. Approved internationally for hepatitis B and C adjuvant therapy.
ā” Quickstart Highlights
Dosing & Reconstitution Guide
Route: Subcutaneous | Frequency: Once daily | Half-life: ~2 hours
Standard Approach (3 mL = 3.33 mg/mL)
Reconstituting with 3 mL bacteriostatic water produces a concentration of 3.33 mg/mL. Volume per dose changes with concentration; mg dose itself does not change between vial sizes.
| Phase / Protocol | Dose | U-100 Units | Volume | Doses per vial |
|---|---|---|---|---|
| Week 1 (titration) | 300 mcg | 9 units | 0.090 mL | 33 doses |
| Weeks 2ā8+ (target) | 500 mcg | 15 units | 0.15 mL | 20 doses |
Reconstitution Steps
- Wipe the vial stopper and BAC water vial with alcohol; let dry.
- Draw 3 mL of bacteriostatic water into a sterile syringe.
- Inject slowly down the inside glass wall of the peptide vial. Do not aim at the powder.
- Gently swirl until fully dissolved. Do not shake.
- Label with reconstitution date. Refrigerate at 2ā8Ā°C; use within 7 days.
Supplies Needed
Estimates for an 8-week and 12-week cycle at 500 mcg per dose, once daily (7 doses/week).
| Item | 8-Week Cycle | 12-Week Cycle |
|---|---|---|
| Thymosin Alpha-1 (10 mg) vials | 3 vials | 5 vials |
| Insulin syringes (U-100) | 56 | 84 |
| Bacteriostatic water (10 mL) | 1 Ć 10 mL | 2 Ć 10 mL |
| Alcohol swabs | 1 Ć 100-pack | 2 Ć 100-pack |
Protocol Overview
Thymosin Alpha-1 (TĪ±1) protocols mirror the international hepatitis-adjuvant clinical use ā twice-weekly subcutaneous injection for 6+ months. Immune-modulatory effects accumulate over 8ā12 weeks; longer cycles produce more sustained T-cell shifts.
Dosing Protocol
Daily titration (subcutaneous):
- Week 1 (titration): 300 mcg/day.
- Weeks 2ā8+ (target): 500 mcg/day. Most-cited research dose.
Cycle structure: 12ā16 weeks for acute support; some chronic protocols extend to 6+ months continuous.
Timing: Once daily; time of day flexible.
Storage Instructions
| State | Temperature | Duration |
|---|---|---|
| Lyophilized | ā20Ā°C (ā4Ā°F) | Up to 24 months, dry & dark |
| Reconstituted | 2ā8Ā°C (35ā46Ā°F) | Up to 7 days, protect from light |
Important Notes
How This Works
Thymosin Alpha-1 (TĪ±1) is a 28-amino-acid peptide originally isolated from thymus tissue. It enhances T-cell maturation, increases CD4+/CD8+ activity, upregulates MHC class I and II antigen presentation, and modulates dendritic cell function via TLR2/TLR9. Effects also include increased type I interferon and IL-12 production.
Potential Benefits & Side Effects
Potential Benefits
- Approved internationally as adjuvant for chronic hepatitis B and C.
- Enhances T-cell maturation and antigen presentation.
- Studied in cancer adjuvant, sepsis, and post-viral immune dysregulation.
- Excellent safety profile ā adverse events similar to placebo in trials.
Side Effect Profile
- Generally well-tolerated.
- Mild injection-site reactions.
- Rare: transient muscle atrophy or rash.
Lifestyle Factors
- Adequate sleep, vitamin D, and zinc support immune function.
- Anti-inflammatory diet complements immune-modulatory effects.
Injection Technique
- Subcutaneous, rotate sites.